RSV Vaccine Market Growth Prospects, Developments Plans, Future Insights and Trends Analysis Till 2035
The RSV vaccines landscape has transformed significantly since the approval of three RSV vaccines, namely Arexvy, Abrysvo and mRESVIA, since 2023. Ever since then, with the application of more advanced platforms to develop innovative vaccines, the life expectancy of patients with RSV diseases has risen remarkably.
The majority (46%) of the developers were established during the period post-2010. Moreover, there has been an increase in the number of developers entering the RSV vaccine domain over the past decades, reflecting a stable and enticing industry for the new entrants. Examples of developers established post-2020 include (in reverse chronological order, established post-2019) RNApeak (2021), RVAC Medicines (2021), Starna Therapeutics (2021), Vaxmed (2020), Vernagen (2021) and RNAImmune (2020).
It is worth highlighting that around 70 RSV vaccines are under different stages of development for patients suffering with respiratory syncytial virus infections. In fact, over 60% of the RSV vaccines are currently being evaluated in clinical trials to assess the safety and efficacy of these vaccines against RSV diseases.
Over 35% of the RSV vaccines are a type of live attenuated vaccines, owing to the fact that live attenuated vaccines contain a live pathogen and the immune system reacts very well to these vaccines, resulting in a robust and long-lasting immune response. Further, close to 30% of the vaccines are subunit / viral-like-particle vaccines, which only contain inactive fragments of the pathogen and not the whole organism, thus reducing the chances of cross infections. Notable examples of live attenuated vaccines include (in alphabetical order, intramuscular vaccines) ChAdV155-RSV (GlaxoSmithKline), KD-409 (KM Biologics), RSV MEDI ΔM2-2 (National Institute of Allergy and Infectious Diseases) and SP0125 (Sanofi).
Patent analysis: protecting intellectual property generated within RSV vaccines market- The majority (22.4%) of the patents were published in 2022, followed by patents published in 2024 (22.1%). This decrease in the number of patents published in 2023 is indicative of the growing preference for alternative RSV treatments such as monoclonal antibodies. In addition to this, majority (51%) of the patents were filed in North America, followed by Europe (16%). This is an indicative of robust patent activity for RSV vaccines in North America, owing to the recent approvals of several RSV vaccines in the respective region. However, the continuous expansion of RSV vaccine market is anticipated to drive patent filings as companies strive to differentiate their product portfolio to meet healthcare needs.
Clinical trial analysis – evaluating the overall potential of RSV vaccines market- Most of the clinical trials assessing the safety and efficacy of these RSV vaccines in human beings, are in phase I (38%). This can be attributed to the fact that the application of RSV vaccines has shown a significant prevention of RSV and related complications among vulnerable patient groups. Owing to which, an upsurge has been witnessed in the R&D activity in this domain, and a large number of novel vaccine candidates have been identified that are being currently evaluated in the early phases of clinical trials. Additionally, it is worth highlighting that 31% of the clinical trials evaluating RSV vaccines are phase III studies, indicating that in the coming years more targeted drugs are likely to enter the RSV vaccine market.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/rsv-vaccine-market.html
About Roots Analysis
Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors.
Why Use Roots Analysis in era of Artificial Intelligence?
1. Tailored Insights
2. Robust Methodology
3. Smart Decisions Made Easy
By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry.
Services Offered:
1. Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work)
Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors.
They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans.
Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation.
2. Subscription Services (bundled services supporting multiple topics and domains for a firm)
With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats.
The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively.
Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights.
Contact Details for Roots Analysis
Chief Executive: Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com
Website:
https://www.rootsanalysis.com/
Browse for more related reports
https://pad.ifcat.org/s/kpifLxBe1 https://gitlab.cranecloud.io/johnwick5911/roots/-/issues/1 https://lospromotores.net/author/johnwick89/ https://www.baytalfann.com/profile/km306515890794/profile https://openprofile.dev/profile/johnwick90 https://demo.playtubescript.com/@johnwick99?page=about https://classmill.com/mkhanna https://glif.app/@M-6932 https://frenchdistrict.com/annonces/author/johnwick90/ https://www.ascecuba.org/profile/km306515841060/profile https://paizo.com/people/john993#newPost https://www.wearecora.org/profile/km306515892403/profile https://git.tbaer.de/johnwick90/Roots/issues/1 https://api.pushcrew.com/discuss/68be9b4b05b7ffe44113df59 https://sailorslife.in/question/probiotic-market-size-share-growth-factors-competitive-landscape-with-regional-forecast-to-2035/ https://www.callupcontact.com/b/businessprofile/nutrigenomics_market/9750313 https://www.halaltrip.com/user/profile/249273/jhanvi99/ https://londonchinese.com/home.php?mod=space&uid=593042&do=profile https://slideslive.com/spwz0dhyfnwo?tab=about https://www.weddingbee.com/members/jhanvikukreja416/ https://kai-you.net/u/jhanvi66 https://www.slideshare.net/jhanvikukreja416 https://cuchichi.es/author/jhanvi816/ https://www.scribd.com/user/855073394/jhanvikukreja416 https://www.goodreads.com/user/show/192672296-jhanvi-kukreja https://gravatar.com/jhanvikukreja416 https://soundcloud.com/jhanvi-kukreja-395028342 https://www.ted.com/profiles/49685180 https://www.tripadvisor.com/Profile/832jhanvik https://www.spreaker.com/podcast/nutrigenomics-market--6701804 https://pbase.com/chris890/inbox https://www.smitefire.com/profile/jhanvi81-222792?profilepage https://memo.cash/profile/1N78Ky4nxCasWxPvxaRXa3apNobKVTvaZx https://www.asklent.com/user/jhanvi99#gsc.tab=0 https://www.gog.com/u/jhanvikukreja416_7 RSV Vaccine Market Growth Prospects, Developments Plans, Future Insights and Trends Analysis Till 2035
The RSV vaccines landscape has transformed significantly since the approval of three RSV vaccines, namely Arexvy, Abrysvo and mRESVIA, since 2023. Ever since then, with the application of more advanced platforms to develop innovative vaccines, the life expectancy of patients with RSV diseases has risen remarkably.
The majority (46%) of the developers were established during the period post-2010. Moreover, there has been an increase in the number of developers entering the RSV vaccine domain over the past decades, reflecting a stable and enticing industry for the new entrants. Examples of developers established post-2020 include (in reverse chronological order, established post-2019) RNApeak (2021), RVAC Medicines (2021), Starna Therapeutics (2021), Vaxmed (2020), Vernagen (2021) and RNAImmune (2020).
It is worth highlighting that around 70 RSV vaccines are under different stages of development for patients suffering with respiratory syncytial virus infections. In fact, over 60% of the RSV vaccines are currently being evaluated in clinical trials to assess the safety and efficacy of these vaccines against RSV diseases.
Over 35% of the RSV vaccines are a type of live attenuated vaccines, owing to the fact that live attenuated vaccines contain a live pathogen and the immune system reacts very well to these vaccines, resulting in a robust and long-lasting immune response. Further, close to 30% of the vaccines are subunit / viral-like-particle vaccines, which only contain inactive fragments of the pathogen and not the whole organism, thus reducing the chances of cross infections. Notable examples of live attenuated vaccines include (in alphabetical order, intramuscular vaccines) ChAdV155-RSV (GlaxoSmithKline), KD-409 (KM Biologics), RSV MEDI ΔM2-2 (National Institute of Allergy and Infectious Diseases) and SP0125 (Sanofi).
Patent analysis: protecting intellectual property generated within RSV vaccines market- The majority (22.4%) of the patents were published in 2022, followed by patents published in 2024 (22.1%). This decrease in the number of patents published in 2023 is indicative of the growing preference for alternative RSV treatments such as monoclonal antibodies. In addition to this, majority (51%) of the patents were filed in North America, followed by Europe (16%). This is an indicative of robust patent activity for RSV vaccines in North America, owing to the recent approvals of several RSV vaccines in the respective region. However, the continuous expansion of RSV vaccine market is anticipated to drive patent filings as companies strive to differentiate their product portfolio to meet healthcare needs.
Clinical trial analysis – evaluating the overall potential of RSV vaccines market- Most of the clinical trials assessing the safety and efficacy of these RSV vaccines in human beings, are in phase I (38%). This can be attributed to the fact that the application of RSV vaccines has shown a significant prevention of RSV and related complications among vulnerable patient groups. Owing to which, an upsurge has been witnessed in the R&D activity in this domain, and a large number of novel vaccine candidates have been identified that are being currently evaluated in the early phases of clinical trials. Additionally, it is worth highlighting that 31% of the clinical trials evaluating RSV vaccines are phase III studies, indicating that in the coming years more targeted drugs are likely to enter the RSV vaccine market.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/rsv-vaccine-market.html
About Roots Analysis
Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors.
Why Use Roots Analysis in era of Artificial Intelligence?
1. Tailored Insights
2. Robust Methodology
3. Smart Decisions Made Easy
By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry.
Services Offered:
1. Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work)
Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors.
They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans.
Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation.
2. Subscription Services (bundled services supporting multiple topics and domains for a firm)
With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats.
The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively.
Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights.
Contact Details for Roots Analysis
Chief Executive: Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/
Browse for more related reports
https://pad.ifcat.org/s/kpifLxBe1
https://gitlab.cranecloud.io/johnwick5911/roots/-/issues/1
https://lospromotores.net/author/johnwick89/
https://www.baytalfann.com/profile/km306515890794/profile
https://openprofile.dev/profile/johnwick90
https://demo.playtubescript.com/@johnwick99?page=about
https://classmill.com/mkhanna
https://glif.app/@M-6932
https://frenchdistrict.com/annonces/author/johnwick90/
https://www.ascecuba.org/profile/km306515841060/profile
https://paizo.com/people/john993#newPost
https://www.wearecora.org/profile/km306515892403/profile
https://git.tbaer.de/johnwick90/Roots/issues/1
https://api.pushcrew.com/discuss/68be9b4b05b7ffe44113df59
https://sailorslife.in/question/probiotic-market-size-share-growth-factors-competitive-landscape-with-regional-forecast-to-2035/
https://www.callupcontact.com/b/businessprofile/nutrigenomics_market/9750313
https://www.halaltrip.com/user/profile/249273/jhanvi99/
https://londonchinese.com/home.php?mod=space&uid=593042&do=profile
https://slideslive.com/spwz0dhyfnwo?tab=about
https://www.weddingbee.com/members/jhanvikukreja416/
https://kai-you.net/u/jhanvi66
https://www.slideshare.net/jhanvikukreja416
https://cuchichi.es/author/jhanvi816/
https://www.scribd.com/user/855073394/jhanvikukreja416
https://www.goodreads.com/user/show/192672296-jhanvi-kukreja
https://gravatar.com/jhanvikukreja416
https://soundcloud.com/jhanvi-kukreja-395028342
https://www.ted.com/profiles/49685180
https://www.tripadvisor.com/Profile/832jhanvik
https://www.spreaker.com/podcast/nutrigenomics-market--6701804
https://pbase.com/chris890/inbox
https://www.smitefire.com/profile/jhanvi81-222792?profilepage
https://memo.cash/profile/1N78Ky4nxCasWxPvxaRXa3apNobKVTvaZx
https://www.asklent.com/user/jhanvi99#gsc.tab=0
https://www.gog.com/u/jhanvikukreja416_7
